15–19 April 2013, Prague, Czech Republic
Reitox Academy Training course: Contemporary approaches in drug monitoring
The training course is organised in cooperation with the Department of Addictology of the First Faculty of Medicine of Charles University.
‘Why is drug monitoring and data collection needed and what information is needed for various audiences? How could novel methods and academic research data be used in the context of monitoring and analysing the drug situation?’ are two main questions which will be discussed in-depth during this five-and-a-half-day training course.
Each training day is dedicated to one main topic linked to the EMCDDA reference framework for monitoring the drug situation:
Day 1 — Monitoring the drugs situation: a reference framework
Day 2 — Trends and patterns in drug use and related monitoring challenges
Day 3 — An integrated response to drugs
Day 4 — Phenomenon of new drugs
Day 5 — From monitoring to action
On the last day of the training, participants will take a test to demonstrate how well they understand the concept of drug monitoring and to demonstrate their knowledge of collection and interpretation of drug-related data, using the quantitative and qualitative tools and methods for analysis.
The course is targeted towards professionals, scientists and administrators working at national drug monitoring bodies or persons closely linked to national activities aimed at consolidation of national drug monitoring systems in Acceding, Candidate and Potential Candidate countries and other non-EU countries. The Academy training course will also be open to professionals representing the Reitox network and students from the First Faculty of Medicine of Charles University. The course is open to register a maximum of 40 participants.
12–14 February 2013, Brussels and Bruges, Belgium
Reitox Academy Professional Training course for IPA beneficiaries: The European Union, the EU drugs policy and the enlargement process under the Lisbon Treaty
The training course is organised in cooperation with the College of Europe, the world’s first university institute of postgraduate studies and training in European affairs, and the leading place to study the European Union, its policies and its institutions. In addition, speakers representing DG Justice, DG Enlargement, the Council of the European Union, the European Parliament and the EMCDDA Management Board are invited to give an overview of their activities, with regards to EU drug policy issues.
The course will provide participants with an overview of the EU and dynamics of European integration, post-Lisbon institutional set-up, in particular for enlargement and drug issues. The participants will also learn critical steps in drafting, implementation and evaluation of the EU strategies and action plans in the field of drugs and will exchange experience on requirements and use of the EU funding instruments. In order to enhance debate and exchange of experience on how countries address the challenges encountered during accession periods and beyond, case studies of Croatia and Slovenia will be presented.
A total of 22 participants representing Albania, Bosnia and Herzegovina, Croatia, the Former Yugoslav Republic of Macedonia, Kosovo*, Montenegro, Serbia, and Turkey are registered for the course.
* This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence